John Overdeck’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

John Overdeck’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-484,508	Closed	-$13.1M	–	3349
2015 Q4	$13.1M	Buy	+484,508	New	+$12.5M	0.06%	342
2015 Q3	–	Sell	-49,283	Closed	-$1.41M	–	3121
2015 Q2	$1.41M	Sell	49,283 -314,611	-86%	-$9.17M	0.01%	1428
2015 Q1	$9.95M	Sell	363,894 -223,427	-38%	-$6.15M	0.05%	466
2014 Q4	$15.5M	Buy	+587,321	New	+$17.2M	0.09%	294
2014 Q3	–	Sell	-42,283	Closed	-$1.33M	–	2304
2014 Q2	$1.33M	Buy	42,283 +3,986	+10%	+$127K	0.01%	1187
2014 Q1	$1.24M	Buy	+38,297	New	+$1.34M	0.01%	1119

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

John Overdeck's MR Position: Q1 2016 in Review

John Overdeck sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 484,508 shares — an estimated $13.1M sold.

John Overdeck first reported a position in MR in Q1 2014 and held it in 6 quarters. The position peaked at $15.5M in Q4 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

John Overdeck reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
John Overdeck sold 484,508 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $13.1M.
John Overdeck first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q1 2014 and held it in 6 quarters.
John Overdeck's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $15.5M in Q4 2014.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Two Sigma Investments's 13F filing for Q1 2016, filed 16 May 2016.